TORONTO, ON / ACCESSWIRE / April 14, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formulations intended f.
TORONTO, ON / ACCESSWIRE / June 14, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI.H) ("Intellipharmaceutics" or the "Company"), announced today that its common stock, currently traded on the OTCQB market, is expected to be downgraded to the OTC Expert Market on June 1.
CALGARY, AB / ACCESSWIRE / June 14, 2024 / FLYHT Aerospace Solutions Ltd. ("FLYHT" or the "Company") (TSXV:FLY)(OTCQX:FLYLF) today announced that it will hold its Annual General and Special Meeting (AGM)
Jasper Commerce Inc. today announced that it has settled the terms of an asset purchase agreement pursuant to which Jasper is to sell its Product Information Management business and related assets.
Vancouver, British Columbia (Newsfile Corp. - June 14, 2024) - Jasper Commerce Inc. (TSXV: JPIM) ("Jasper" or the "Company") today announced that it has settled the terms of an asset purchase agreement